论文部分内容阅读
摘要目的采用定量MR动态对比增强成像(DCEMRI)测量乳腺癌的各药代动力学参数,以探究DCE-MRI在不同亚型乳腺癌的新辅助治疗疗效评估方面的应用价值。方法纳入84例行新辅助治疗的进展期乳腺癌病例,回顾性分
Abstract Objective To measure the pharmacokinetic parameters of breast cancer by quantitative MR dynamic contrast-enhanced imaging (DCEMRI) to explore the value of DCE-MRI in evaluating the efficacy of neoadjuvant therapy in different subtypes of breast cancer. Methods Eighty-four patients with advanced breast cancer undergoing neoadjuvant therapy were retrospectively analyzed